Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute escitalopram crossover study of emotional processing by 5-HTT genotype
ACTRN12611000719932Phase 4Completed
- Sponsor
- The University of Sydney
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of escitalopram in major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by The University of Sydney. Primary endpoints: fMRI BOLD responses during viewing of emotional images and EEG alpha asymmetry and heart rate variability. Started Jul 2011; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on ACTRN12611000719932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000719932.